Investors with a lot of money to spend have taken a bearish stance on Bristol-Myers Squibb BMY.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with BMY, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for Bristol-Myers Squibb.
This isn't normal.
The overall sentiment of these big-money traders is split between 20% bullish and 80%, bearish.
Out of all of the options we uncovered, 9 are puts, for a total amount of $525,443, and there was 1 call, for a total amount of $29,800.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $70.0 for Bristol-Myers Squibb over the last 3 months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Bristol-Myers Squibb's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bristol-Myers Squibb's whale activity within a strike price range from $40.0 to $70.0 in the last 30 days.
Bristol-Myers Squibb Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | PUT | TRADE | NEUTRAL | 01/17/25 | $1.1 | $1.06 | $1.08 | $40.00 | $108.0K | 5.6K | 1.0K |
| BMY | PUT | SWEEP | BEARISH | 10/18/24 | $8.25 | $8.15 | $8.25 | $57.50 | $107.2K | 55 | 130 |
| BMY | PUT | SWEEP | BEARISH | 09/20/24 | $6.15 | $5.95 | $6.05 | $55.00 | $68.9K | 1.0K | 0 |
| BMY | PUT | TRADE | BEARISH | 01/17/25 | $1.09 | $1.04 | $1.08 | $40.00 | $54.0K | 5.6K | 1.0K |
| BMY | PUT | SWEEP | BULLISH | 05/16/25 | $3.25 | $2.79 | $2.79 | $45.00 | $46.8K | 354 | 168 |
About Bristol-Myers Squibb
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
In light of the recent options history for Bristol-Myers Squibb, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of Bristol-Myers Squibb
- Trading volume stands at 11,739,521, with BMY's price down by -2.29%, positioned at $49.14.
- RSI indicators show the stock to be may be approaching oversold.
- Earnings announcement expected in 14 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Bristol-Myers Squibb, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
